Top Markets
Coin of the day
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Rang in aandelen #41072
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Aandeelprijs
$0.0005
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$16.62K
Verandering (1 dag)
-64.29%
Verandering (1 jaar)
400.00%
Land
US
Handel WayPoint Biomedical Holdings, Inc. (WYPH)

Categorie

P/B-ratio voor WayPoint Biomedical Holdings, Inc. (WYPH)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van WayPoint Biomedical Holdings, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor WayPoint Biomedical Holdings, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
15.9335 -
US
- -
CA
3.177 -
US
5.4964 -
AU
3.3416 -
US